Saturday 17 October 2026 Export COLL’s income statement to Excel — free account

Collegium Pharmaceutical, Inc.

COLL Healthcare Drug Manufacturers Specialty & Generic

Collegium Pharmaceutical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $780.6 million, up 23.6% from fiscal 2024. In the quarter to June 2026, revenue grew 6.32%, EPS fell 221.1%, free cash flow fell 2.14% and total debt rose 32.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

23.19 0.01 +0.04%

Follow COLL

Alert me

Market cap: $754.6M
P/E: 15.2×
Fwd P/E: 12.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.58
Beneish M: −3.32
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	22.96%	23.70%	27.41%	17.61%
Piotroski F-Score Full definition →		7	7	9	6
ROA Full definition →		3.60%	3.79%	4.57%	2.57%
ROIC Full definition →		12.62%	15.94%	17.52%	7.85%
Return on Tangible Assets Full definition →		33.75%	23.87%	23.25%	166.34%
Average Days of Receivables Full definition →		112.79	98.82	104.85	128.76
Free Cash Flow per Share Full definition →		9.16	10.33	10.28	10.11
Free Cash Flow Full definition →		289.30	327.58	329.83	328.28
Capital Expenditures Full definition →		(1.62)	(1.74)	(1.21)	(1.64)
Other line items
Cash ROIC Full definition →		20.83%	21.59%	21.19%	21.14%
Accounts Receivable Turnover Full definition →		3.27	3.55	3.48	3.25
Accounts Payable Turnover Full definition →		60.04	43.49	25.38	32.10
Inventory Turnover Full definition →		8.51	8.30	7.83	4.27
Average Days of Payables Full definition →		8.62	12.26	7.96	10.44
Days of Inventory on Hand Full definition →		42.88	47.06	49.82	127.95
Tax Rate Full definition →		(0.28)	(0.32)	(0.31)	(0.38)
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		37.02%	36.49%	37.01%	40.54%
Share Based Compensation of Revenue Full definition →		5.25%	5.37%	5.18%	5.56%
Interest Coverage Full definition →		1.83	2.18	2.44	2.06
Operating CF/Net income Full definition →		4.98	5.24	4.42	6.89
Depreciation/Fixed assets Full definition →		18.37	18.73	19.25	21.86
Capex/Depreciation Full definition →		(0.01)	(0.01)	(0.01)	(0.01)
Revenue per Share Full definition →		23.98	24.62	24.82	24.90
Operating CF per Share Full definition →		9.21	10.39	10.32	10.16
Capex per Share Full definition →		(0.05)	(0.05)	(0.04)	(0.05)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly